Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors relief of jaundice is seldom achieved, despite successful endoprosthesis insertion. Additional photodynamic therapy seems to be a promising new approach to these tumors. First pilot studies show relief of jaundice, mainly because of opening of the intrahepatic ducts and improvements in quality of life indices. Survival time seems to be long; however, randomized studies are necessary to confirm these results
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors r...
Cholangiocarcinoma is a challenge to manage; mortality rate is nearly as high as the incidence. Unle...
BACKGROUND & AIMS: Successful treatment in nonresectable Bismuth type III and IV cholangiocarcin...
Biliary tract cancers are rare malignancies usually characterized by slow growth and a low propensit...
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time ...
Hilar cholangiocarcinoma is a fatal malignancy leading to high mortality rate despite recent therape...
The prognosis of bile duct cancer (BDC) is limited due to tumor spread along the biliary tree leadin...
Cholangiocarcinoma is, in most cases, rapidly fatal. Curative resection can only be offered to appro...
AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photo...
The results of the pilot study of combined treatment for non-resectable cholangiocarcinoma complicat...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors r...
Cholangiocarcinoma is a challenge to manage; mortality rate is nearly as high as the incidence. Unle...
BACKGROUND & AIMS: Successful treatment in nonresectable Bismuth type III and IV cholangiocarcin...
Biliary tract cancers are rare malignancies usually characterized by slow growth and a low propensit...
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time ...
Hilar cholangiocarcinoma is a fatal malignancy leading to high mortality rate despite recent therape...
The prognosis of bile duct cancer (BDC) is limited due to tumor spread along the biliary tree leadin...
Cholangiocarcinoma is, in most cases, rapidly fatal. Curative resection can only be offered to appro...
AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photo...
The results of the pilot study of combined treatment for non-resectable cholangiocarcinoma complicat...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...